Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Methods (San Diego, Calif.)|February 22, 2005
Informatics for protein identification by mass spectrometryRichard S Johnson, Michael T Davis, J Alex Taylor, et al.Molecular Biotechnology|November 27, 2002
Searching sequence databases via de novo peptide sequencing by tandem mass spectrometryRichard S Johnson, J Alex TaylorProteomics. Clinical Applications|December 8, 2010
Cancer biomarker discovery via low molecular weight serum proteome profiling - Where is the tumor?Michael T Davis, Paul Auger, Chris Spahr, et al.Proteomics|January 27, 2010
Maximizing the sensitivity and reliability of peptide identification in large-scale proteomic experiments by harnessing multiple search enginesWen Yu, J Alex Taylor, Michael T Davis, et al.Biotechniques|November 23, 2023
Decoding disease: Scott Patterson's perspectives on the power of biomarkers in drug developmentScott D PattersonPharmaceutical Statistics|December 14, 2011
Viewpoint: observations on scaled average bioequivalenceScott D Patterson, Byron JonesPharmaceutical Statistics|May 4, 2007
A brief review of Phase 1 and Clinical Pharmacology statistics in clinical drug developmentScott D Patterson, Byron JonesPlos One|October 15, 2014
Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experienceMichael B Bass, Bin Yao, Yong-Jiang Hei, et al.Expert Opinion on Drug Discovery|March 19, 2013
The role of biomarkers in the future of drug developmentScott D Patterson, Robert F DuboseTrends in Biotechnology|February 7, 2003
Proteomics: drug target discovery on an industrial scaleTerence E Ryan, Scott D PattersonPageof 9